IGOR FRANCETIĆ, M.D.; LOUIS LASAGNA, M.D.; MICHAEL WEINTRAUB, M.D.; FRED E. KARCH, M.D.
We evaluated the New York State generic substitution law. This law mandates substitution of a less expensive product if the physician signs the prescription for an eligible brand name drug on the line marked "substitution permissible." We purchased drugs by brand name and generically before the law went into effect. Later, we purchased the same drugs in the same stores using the formats "brand-dispense-as-written," "brand-substitution-permissible," and "generic." Mean savings from generic prescribing or substitution increased from 12.1% ± 20.4% before the law to 26.2% ± 10.5% (brand-substitution-permissible) and 27.2% ± 14.2% (generic). Prices for the same drug written the same way varied enormously among pharmacies. Brand-dispense-aswritten, brand-substitution-permissible, and generic prices in the same store varied substantially and unpredictably. Savings were not passed on to consumers in 29% of postlaw comparisons. Assuring maximal savings requires extensive comparison shopping.
FRANCETIĆ I, LASAGNA L, WEINTRAUB M, KARCH FE. Prescription Prices Under the New York Generic Substitution Law. Ann Intern Med. 1980;92:419–423. doi: 10.7326/0003-4819-92-3-419
Download citation file:
Published: Ann Intern Med. 1980;92(3):419-423.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use